Press release
Key Influencer in the Zika Virus Therapeutics Market 2025: Rising Infection Rates Propel Growth In The Market Driver
Zika Virus Therapeutics
The high incidence of infection is expected to drive the growth of the Zika virus therapeutics market. The incidence rate refers to the number of new infection cases in a population within a defined period. Factors such as inadequate vector control and environmental conditions favoring mosquito breeding contribute to the rise in infections. Increased infection rates demand effective therapeutics, driving the development of vaccines and treatments. For instance, in December 2024, the UK Health Security Agency reported a 700% increase in Zika virus cases between January and June 2024 compared to the same period in 2023. Therefore, the rising infection rate will propel the growth of the Zika virus therapeutics market.
Get Your Zika Virus Therapeutics Market Report Here:
https://www.thebusinessresearchcompany.com/report/zika-virus-therapeutics-global-market-report
What growth opportunities are expected to drive the zika virus therapeutics market's CAGR through 2034?
The zika virus therapeutics market has grown substantially in recent years. It is forecasted to grow from $30.22 billion in 2024 to $32.16 billion in 2025 at a CAGR of 6.4%. The market's expansion has been driven by the high infection rate, the burden of zika virus-related comorbidities, a rising demand for preventive measures, the increasing significance of public health campaigns, and the expansion of global health initiatives.
The Zika virus therapeutics market is projected to grow significantly, reaching $40.64 billion by 2029, with a CAGR of 6.0%. This growth is attributed to the rising adoption of clinical trials, increasing demand for Zika virus therapeutics in endemic regions, greater R&D investments, the availability of serology kits for diagnosis, and alternative treatment programs. Key trends include technological advancements in antiviral drug development, innovations in serological testing, breakthroughs in monoclonal antibody research, and the development of novel therapies and rapid diagnostics.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21323&type=smp
What are the emerging trends shaping the future of the zika virus therapeutics market?
In the Zika virus therapeutics market, companies are focusing on second-generation adjuvanted inactivated vaccines to improve immune response and provide long-lasting protection. Valneva SE, a France-based biotechnology company, initiated Phase 1 clinical trials in March 2024 for VLA1601, a highly purified, inactivated Zika virus vaccine. Developed with the same platform as the Japanese encephalitis vaccine IXIARO, the adjuvanted vaccine aims to boost the immune response, offering enhanced protection against Zika virus infection.
Which growth-oriented segments of the zika virus therapeutics market are leading the industry's development?
The zika virus therapeutics market covered in this report is segmented -
1) By Product: Acetaminophen, Other Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
2) By Vaccine Type: Inactivated Vaccine, Subunit Vaccine, Live-Attenuated Vaccine, Other Vaccine Types
3) By End User: Hospitals, Clinics, Other End Users
Subsegments:
1) By Acetaminophen: Oral Tablets, Oral Suspensions, Intravenous Formulations
2) By Other Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Ibuprofen, Aspirin, Naproxen, Celecoxib
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21323
What regions are leading the charge in the zika virus therapeutics market?
North America was the largest region in the zika virus therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the zika virus therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What companies are at the forefront of innovation in the zika virus therapeutics market?
Major companies operating in the zika virus therapeutics market are Johnson & Johnson, F. Hoffmann-La Roche AG, Merck & Co. Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited, Moderna Inc., DiaSorin S.p.A., Emergent BioSolutions Inc., ARUP Laboratories, Valneva SE, Bharat Biotech International Limited, Euroimmun AG, Tiangen Biotech Co. Ltd., Creative Diagnostics, Inovio Pharmaceuticals Inc., GeoVax Labs Inc., Moleculin Biotech Inc., BioVaxys Technology Corp., Kimer Med Limited, LumiQuick Diagnostics Inc.
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=21323&type=smp
What Is Covered In The Zika Virus Therapeutics Global Market Report?
•Market Size Forecast: Examine the zika virus therapeutics market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the zika virus therapeutics market for a structured understanding.
•Key Players Overview: Analyze major players in the zika virus therapeutics market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the zika virus therapeutics market.
•Segment Contributions: Evaluate how different segments drive overall growth in the zika virus therapeutics market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the zika virus therapeutics market.
•Industry Challenges: Identify potential risks and obstacles affecting the zika virus therapeutics market.
•Competitive Landscape: Review strategic developments in the zika virus therapeutics market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Key Influencer in the Zika Virus Therapeutics Market 2025: Rising Infection Rates Propel Growth In The Market Driver here
News-ID: 3934798 • Views: …
More Releases from The Business Research Company
Rising Incidence of Dental Disorders Sparks Growth in the Tooth-Filling Material …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Tooth Filling Materials Market Through 2025?
In the past few years, the market size for tooth filling materials has experienced robust growth. Projected to rise from $1.82 billion in 2024 to $1.92 billion in 2025, it's set to journey at a compound…
2025-2034 Stress Tests Equipment Market Outlook: Key Drivers, Emerging Challenge …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Stress Tests Equipment Industry Market Size Be by 2025?
In recent years, the market for stress test equipment has seen robust growth. From a value of $2.99 billion in 2024, it is projected to increase to $3.19 billion in 2025, reflecting a compound annual growth rate…
2025 Positron Emission Tomography (PET) Scanners Industry Trends Report: Long-Te …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Positron Emission Tomography (PET) Scanners Market Size By 2025?
The market size for positron emission tomography (pet) scanners has been witnessing a steady increment in the past years. The market is expected to escalate from $1.51 billion in 2024 to $1.58 billion in 2025, registering…
Strategic Forecast for the Ostomy Devices Industry: Market Outlook 2025-2034
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Ostomy Devices Market Size Growth Forecast: What to Expect by 2025?
In the past few years, the ostomy devices market has been consistently expanding. Projections show an increase from $2.8 billion in 2024 to $2.9 billion in 2025, maintaining a compound annual growth rate (CAGR) of 3.9%. The significant…
More Releases for Zika
Zika Virus Vaccines Market 2022 | High rate of incidence of active Zika virus in …
Zika Virus Vaccines Market Report, published by Allied Market Research, forecasts that the global market is expected to garner $18,697 million by 2022, registering a CAGR of 5.2% during the forecast period 2017-2022.Key opportunities include the need for vaccines for immunization & prevention of further spread of Zika virus infection and for treatment of Zika-linked birth defects.
Do Enquiry for Sample Report @ https://www.alliedmarketresearch.com/request-sample/1817
The outbreak of Zika virus infection in Latin…
Zika Vaccines Market Size, Share, Development by 2023
New report published by Market Research Report Store (MRRS) which offers insights on the global Zika Vaccines market.
Click to view the full report TOC, figure and tables:
https://www.marketresearchreportstore.com/reports/212025/global-zika-vaccines-market
Global Zika Vaccines Market: Forecast by Type / Application / Region
According to this study, over the next five years the Zika Vaccines market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2023, from…
Global Zika Virus Market Research Report 2017
Qyresearchreports include new market research report "Global Zika Virus Market Research Report 2017" to its huge collection of research reports.
The global market for Zika Virus has been marked on several factors that are on the verge or have already impacted the growth of the market in several contexts. The report further pronounces different statistics and data pertaining to the global Zika Virus market. The core aim of the report is…
Global Zika Virus Market Research Report 2017
The Global Zika Virus 2017 Market Research Report is a professional and in-depth study on the current state of the Zika Virus industry.
Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Zika Virus market analysis is provided for the international market including development history, competitive landscape analysis, and major regions’ development status.
Secondly, development policies and plans are discussed as well…
Zika Vaccines Market - Global Industry Insights 2025
Zika vaccines are developed for immunization & prevention against diseases caused by Zika virus. This virus belongs to genus Flavivirus and is transmitted by Aedes mosquitoes. The virus can also be transmitted through blood transfusion, sexual contact or from infected pregnant women to the fetus. Diagnosis of this infection is confirmed by detecting viral DNA through PCR. However, only 1 in 4 people with zika infection are prone to develop…
Zika Virus Consumption 2016 Market Research Report
Qyresearchreports include new market research report Global Zika Virus Consumption 2016 Market Research Report to its huge collection of research reports.
This report is a descriptive and analytical dissemination of information in the Zika Virus, for those associated with it or those who wish to enter the market in the immediate future. The report provides – within its predetermined forecast period – the latest installment of this stream of research reports.…
